---
title: "KINDLY MD INC C/WTS 31/05/2029 (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 579.66 K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239431037.md"
datetime: "2025-05-08T21:31:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239431037.md)
  - [en](https://longbridge.com/en/news/239431037.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239431037.md)
---

# KINDLY MD INC C/WTS 31/05/2029 (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 579.66 K

Revenue: As of FY2025 Q1, the actual value is USD 579.66 K.

EPS: As of FY2025 Q1, the actual value is USD -0.17.

EBIT: As of FY2025 Q1, the actual value is USD -1.038 M.

### Segment Revenue

-   **Patient Care Services**: Revenue decreased to $570,936 for the three months ended March 31, 2025, from $785,843 for the same period in 2024.
-   **Product Retail Sales**: Revenue decreased significantly to $823 for the three months ended March 31, 2025, from $43,186 for the same period in 2024.
-   **Service Affiliate Agreements**: Revenue was $7,896 for the three months ended March 31, 2025, with no comparable revenue in 2024.

### Operational Metrics

-   **Net Loss**: The net loss increased to - $1,038,011 for the three months ended March 31, 2025, compared to - $282,326 for the same period in 2024.
-   **Operating Expenses**: Total operating expenses increased to $1,621,396 for the three months ended March 31, 2025, from $1,066,156 for the same period in 2024.
-   **Salaries and Wages**: Increased by $295,211, or 41.7%, to $1,003,177 for the three months ended March 31, 2025.
-   **General and Administrative Expenses**: Increased by $302,309, or 104.2%, to $592,437 for the three months ended March 31, 2025.

### Cash Flow

-   **Net Cash Used in Operating Activities**: - $865,083 for the three months ended March 31, 2025, compared to - $213,439 for the same period in 2024.
-   **Net Cash Used in Investing Activities**: - $173,448 for the three months ended March 31, 2025, compared to - $11,182 for the same period in 2024.
-   **Net Cash Used in Financing Activities**: - $94,519 for the three months ended March 31, 2025, compared to - $13,496 for the same period in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: Kindly MD aims to increase cash reserves and liquidity through strategic transactions and optimize revenue by increasing sales, improving margins, and controlling ongoing operating expenses.
-   **Non-Core Business**: No specific plans related to divestitures or emerging segments were mentioned.

### Unique Metrics

-   **Insurance Reimbursements**: The company earned $85,273 in reimbursements from insurance payers during the three months ended March 31, 2025, a 145.6% increase from the $34,772 earned during the same period in 2024.

### Related Stocks

- [KDLYW.US](https://longbridge.com/en/quote/KDLYW.US.md)
- [NAKAW.US](https://longbridge.com/en/quote/NAKAW.US.md)